Slingshot Insights | Bivv Overview

BIVV Overview

Upcoming Projects (BIVV)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (BIVV)

Don’t see a project related to the company you care about? Create your own!

Expired Projects (BIVV)

Comparing Roche’s emicizumab (ACE910) recent Phase 3 HAVEN 1 and 2 results to Bioverativ’s FDA approved Eloctate and Alprolix in the treatment of Hemophilia
Tickers: RHHBY, BIVV, SHPG
Execute By: Aug 18, 2017

Upcoming & Overdue Catalysts (BIVV)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (BIVV)

Bioverativ(BIVV) plans to initiate a Phase 1/2a of BIVV001 to Treat Hemophilia in the second half of 2017
Ticker: BIVV
Occurred on: Aug 02, 2017

Strategic Initiatives (BIVV)

Don’t see a strategic initiative related to the company you care about? Create your own!